Zhengzhou Flamingo International Trade Co., Ltd – Trademark Portfolio

Entity Type: 16

Zhengzhou Flamingo International Trade Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OTUN. The owner is based in Zhengzhou, Henan.

East house, 3rd floor, unit 2, building

Zhengzhou, Henan 450000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OTUN
OTUN
Registered 2020

Trademark Classifications

Zhengzhou Flamingo International Trade Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhengzhou Flamingo International Trade Co., Ltd have?

Zhengzhou Flamingo International Trade Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhengzhou Flamingo International Trade Co., Ltd file in?

Zhengzhou Flamingo International Trade Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhengzhou Flamingo International Trade Co., Ltd's most well-known trademarks?

Zhengzhou Flamingo International Trade Co., Ltd's registered trademark portfolio includes well-known marks such as OTUN. These are among 1 currently registered trademark in the portfolio.

What is Zhengzhou Flamingo International Trade Co., Ltd's trademark registration success rate?

Zhengzhou Flamingo International Trade Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.